Back to Boston Partners Boston Partners

CPRXCPRX
18 quarters

Position history for Boston PartnersBoston Partners's holdings in CATALYST PHARMACEUTICALS INC

Boston Partners holds 1.7M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $52.2M as of 2026-Q2. The position was decreased (-3.1% shares). CPRX represents 0.0% of Boston Partners's portfolio.

Current Value

$52.2M

Current Shares

1.7M

Total Value Change

+$51.5M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-3.1%
$52.2M0.0%$31.43
0
2026-Q1
Increased
1.7M
+39.0%
$42.4M0.0%$23.92
38
2025-Q4
Decreased
1.2M
-4.6%
$28.5M0.0%$23.29
0
2025-Q3
Increased
1.3M
+0.7%
$25.6M0.0%$19.55
29
2025-Q2
Increased
1.3M
+0.6%
$27.9M0.0%$21.78
29
2025-Q1
Decreased
1.3M
-1.3%
$30.6M0.0%$24.69
0
2024-Q4
Increased
1.3M
+1.3%
$27.3M0.0%$21.07
29
2024-Q3
Decreased
1.3M
-9.3%
$25.6M0.0%$19.56
0
2024-Q2
Decreased
1.4M
-6.7%
$22M0.0%$15.49
0
2024-Q1
Decreased
1.5M
-2.3%
$23.8M0.0%$15.94
0
2023-Q4
Increased
1.5M
+965.2%
$25.6M0.0%$16.81
46
2023-Q3
Unchanged
144,730
0.0%
$1.7M0.0%$11.69
0
2023-Q2
Unchanged
144,730
0.0%
$1.9M0.0%$13.53
0
2023-Q1
Unchanged
144,730
0.0%
$2.4M0.0%$16.46
0
2022-Q4
Increased
144,730
+2.4%
$2.7M0.0%$18.60
27
2022-Q3
Increased
141,379
+2.0%
$1.8M0.0%$12.70
26
2022-Q2
Increased
138,558
+82.9%
$971,0000.0%$6.95
39
2022-Q1
New
75,746
-
$628,0000.0%$8.28
34

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used